Clinical Trial Update: Efficacy of Ginseng for Patients on Regorafenib [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether ginseng improves outcomes for patients receiving regorafenib in colorectal cancer. The study was terminated and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ginseng (Panax ginseng)
• Stivarga (regorafenib)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Colorectal Cancer, Palliative Medicine | Phase 2 | Status: TERMINATED | Results posted: 2024-06-26